FDA Comments on Continuous Manufacturing

Article

Christine Moore, acting director in the Office of Process and Facilities at at FDA's Center for Drug Evaluation and Research, spoke with Pharmaceutical Technology at Interphex 2015 about advances in continuous manufacturing, regulatory concerns, and next steps.  

 

Current Time 0:00
Duration 0:00
Loaded: 0%
Stream Type LIVE
Remaining Time 0:00
 
1x
    • Chapters
    • descriptions off, selected
    • captions off, selected

      Recent Videos
      Behind the Headlines, Episode 20: CAR-T Milestones, Abbvie and Eli Lilly M&A Moves, and More
      Behind the Headlines, Episode 20: CAR-T Milestones, Abbvie and Eli Lilly M&A Moves, and More
      DC skyline at night with view of the White House and the Washington Monument | Image Credit: © Jessica - stock.adobe.com
      Key Leaders at BIO 2025 Respond to Continuing Political Shifts
      Ask the Expert: Adventitious Contamination Control
      Ask the Expert: Adventitious Contamination Control
      Behind the Headlines, Episode 19: CGT Cost Pressures, BioNTech’s CureVac Move, and Spain’s CAR-T Model
      Behind the Headlines, Episode 19: CGT Cost Pressures, BioNTech’s CureVac Move, and Spain’s CAR-T Model
      BIO 2025: Pulmonary Drug Delivery
      BIO 2025: Pulmonary Drug Delivery
      Training Centers and eCommerce: A Look Into Federal Equipment Company’s Pharma Innovations
      Training Centers and eCommerce: A Look Into Federal Equipment Company’s Pharma Innovations
      Behind the Headlines, Episode 18
      Behind the Headlines, Episode 18: Sanofi, GSK Go Big in M&A, mRNA Momentum Falters, and More
      From Discovery to Delivery: How Piramal Pharma Limited is Strengthening its Drug Development Capabilities
      From Discovery to Delivery: How Piramal Pharma Limited is Strengthening its Drug Development Capabilities
      A CDMO’s Role in API Quality
      A CDMO’s Role in API Quality
      CPHI Americas 2025: The Evolving Role of the CDMO
      CPHI Americas 2025: The Evolving Role of the CDMO
      Related Content
      Old rusty shovel in the ground on the building | Image Credit: © photolink - stock.adobe.com

      Piramal Pharma Holds Groundbreaking at Kentucky Facility, Part of $90 Million Investment Plan

      Patrick Lavery
      July 2nd 2025
      Article

      The expansion of the Kentucky site accounts for $80 million of the announced investment, with the remaining money earmarked for facilities in Michigan.

      Drug Solutions Podcast: Novel Drug Delivery Approaches: Refining AAV Vector Deliveries

      Drug Solutions Podcast: Novel Drug Delivery Approaches: Refining AAV Vector Deliveries

      Patrick Lavery
      May 30th 2025
      Podcast

      In this podcast episode, we discuss novel approaches to drug delivery, specifically regarding adeno-associated virus (AAV) vectors, as viewed by two industry experts who recently exhibited at the annual ASGCT meeting.

      NÜRNBERG / GERMANY - APRIL 7, 2019: Siemens Logo on an office building in Nürnberg. Siemens is a German engineering company | Image Credit: © filmbildfabrik - stock.adobe.com

      Siemens Finalizes $5.1B Dotmatics Acquisition

      Christopher Cole
      July 1st 2025
      Article

      Siemens expands AI-driven pharma software portfolio, integrating Dotmatics’ platform to connect drug research, development, and manufacturing digitally.

      Site Logo

      Transformations in Drug Development for Cell and Gene Therapies

      PPD;Thermo Fisher Scientific
      March 28th 2025
      Podcast

      As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.

      Science laboratory test tubes, laboratory equipment | Image Credit: © BillionPhotos.com - © BillionPhotos.com - stock.adobe.com

      Hikma Pharmaceuticals Invests $1 Billion to Expand US Generic Drug Capabilities, Releases Sustainability Report

      Susan Haigney
      June 30th 2025
      Article

      The company is expanding its US manufacturing and R&D capabilities with a $1 billion investment by 2030.

      Communication between the manufacturing plant and retail stores. | Image Credit: © Cagkan - © Cagkan - stock.adobe.com

      Aenova Adds Cold Chain Warehouse to Latina, Italy Site

      Susan Haigney
      June 27th 2025
      Article

      The new building expands on the company’s supply chain solutions for biologics and temperature-sensitive pharmaceuticals.